We are a regional biopharma company specializing in the commercialization of innovative biopharmaceutical products targeting severe and rare diseases in South East Europe. Headquartered in Nicosia, Genesis Pharma (Cyprus) Ltd was founded with the mission to ensure that patients suffering from severe and rare diseases, have direct access to innovative branded medicines. Guided by this same mission, the company is operating in the region through its affiliate in Athens Greece and its local subsidiaries in Bulgaria, Romania, Croatia, Slovenia, Serbia, and North Macedonia. The company has established long-term alliances with leading global biopharma companies and is responsible for a unique portfolio which includes innovative biopharmaceuticals that tackle severe and rare diseases. Its novel branded pharmaceutical products cover the therapeutic areas of Haematology, Oncology, Central Nervous System, Nephrology, Gastroenterology, Rheumatology-Dermatology as well as Rare Genetic Inherited diseases. Genesis Pharma (Cyprus) Ltd is affiliated (sister company) to GENESIS Pharma SA in Athens, Greece (www.genesispharma.com).
View Top Employees from Genesis Pharma (Cyprus) LtdWebsite | https://www.genesispharmagroup.com/ |
Revenue | $1 million |
Employees | 6 (6 on RocketReach) |
Founded | 1999 |
Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Biotechnology, Pharmaceuticals, Healthcare |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Genesis Pharma (Cyprus) Ltd employee's phone or email?
The Genesis Pharma (Cyprus) Ltd annual revenue was $1 million in 2023.
6 people are employed at Genesis Pharma (Cyprus) Ltd.
The NAICS codes for Genesis Pharma (Cyprus) Ltd are [3254, 32, 32541, 325].
The SIC codes for Genesis Pharma (Cyprus) Ltd are [283, 28].